Homocysteine and Hypertension in Diabetes: Does PPARγ Have a Regulatory Role?
Dysfunction of macro- and microvessels is a major cause of morbidity and mortality in patients with cardio-renovascular diseases such as atherosclerosis, hypertension, and diabetes. Renal failure and impairment of renal function due to vasoconstriction of the glomerular arteriole in diabetic nephrop...
Main Authors: | Utpal Sen, Suresh C. Tyagi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2010/806538 |
Similar Items
-
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol
by: Mishra Paras K, et al.
Published: (2010-09-01) -
PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice
by: Walter E. Rodriguez, Utpal Sen, Neetu Tyagi, Munish Kumar, Gene Carneal, Deep Aggrawal, Justin Newsome, Suresh C. Tyagi
Published: (2008-01-01) -
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01) -
PPARγ as a potential therapeutic target in pulmonary hypertension
by: Roy L. Sutliff, et al.
Published: (2010-06-01) -
Does Pro12Ala Polymorphism Enhance the Physiological Role of PPARγ2?
by: A. C. Pereira, et al.
Published: (2013-01-01)